Anidulafungin-induced Hepatotoxicity and Dose Reduction: A Case Report
L. W. Loo, Jocelyn Teo, Tan Thuan Tong, Winnie Lee & Andrea L. Kwa · International Journal of Medical and Pharmaceutical Case Reports · 2015
Anidulafungin, the newest echinocandin antifungal recently approved by the U.S. FDA, is unique among echinocandins as it undergoes biotransformation rather than being metabolized. In general, patients who received anidulafungin demonstrated low rates of adverse events. Hepatotoxi...
Open access
Research Article
10.9734/IJMPCR/2016/22272